GlobeNewswire - Industry News on Drug Retailers

Delta 9 to Open Tenth Cannabis Retail Store

Fri, 05 Feb 2021 12:00 GMT

WINNIPEG, Manitoba, Feb. 05, 2021 (GLOBE NEWSWIRE) -- DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”), is pleased to announce the grand opening of its tenth Delta 9 Cannabis retail store, and seventh cannabis store in the Province of Manitoba. Delta 9’s newest retail store is located in the City of Winnipeg and is scheduled to open on February 5, 2021.

TILT Holdings Inc. Announces Exclusive Contract to Manufacture and Distribute Her Highness NYC Branded Products in Massachusetts

Thu, 04 Feb 2021 12:30 GMT

Dedicated to Delivering Experiences that Elevate and Celebrate Women, Her Highness NYC is a Female-Owned, Premium Cannabis Brand with a Portfolio of Products Inspired and Engineered by Women for Women

Delta 9 Achieves Milestone in Agreement with Micro Cultivation Partner

Thu, 04 Feb 2021 12:00 GMT

WINNIPEG, Manitoba, Feb. 04, 2021 (GLOBE NEWSWIRE) -- DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) ("Delta 9" or the "Company"), is pleased to announce that it has completed its final services milestone under an agreement with Alberta based Micro Cultivation partner, Dry Island LTD. (“Dry Island”). Dry Island is an arm’s length third party in which the Company has no ownership control or interest.

The Flowr Corporation Announces Entry into Quebec

Thu, 04 Feb 2021 11:00 GMT

Highlights:

Flowr Corporation annonce son entrée au Québec

Thu, 04 Feb 2021 11:00 GMT

Faits marquants

The Flowr Corporation?Applauds first Market Authorization Approval in Portugal

Wed, 03 Feb 2021 11:00 GMT

Flowr views the market authorizations as a critical next step to opening another E.U. market for medical cannabis.

Flowr views the market authorizations as a critical next step to opening another E.U. market for medical cannabis.

MATEON ANNOUNCES COMPLETION OF ARTI-19 AND PUBLICATION OF POSITIVE INTERIM DATA

Tue, 02 Feb 2021 12:00 GMT

AGOURA HILLS, California, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and infectious diseases, announced that its ARTI-19 trial, evaluating ARTIVeda^? / PulmoHeal^? against COVID-19 in India, has completed randomization of all 120 patients and final analysis is expected in March 2021. Simultaneously, Mateon published positive interim data as preprint at https://www.medrxiv.org/content/10.1101/2021.01.24.21250418v1. Once the article is published in a peer-reviewed journal, medRxiv will update the preprint with a link to the published version.

MATEON LAUNCHES ITS AI TELEMEDICINE PLATFORM FOR POST MARKETING SURVEY TO SUPPORT ITS DRUG PRODUCT FOR INDIA, PULMOHEAL?

Mon, 01 Feb 2021 12:00 GMT

AGOURA HILLS, California, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and infectious diseases, announce today that it has launched its artificial intelligence (AI) telemedicine platform for post marketing survey (PMS) to support the launch of its drug product, PulmoHeal^TM. The PMS module, with its previously announced AI mobile app, ArtiHealth^TM, rounds out the company’s AI telemedicine solution.

MJardin Announces Standing Offer Agreement with Alberta Gaming, Liquor and Cannabis

Thu, 28 Jan 2021 13:00 GMT

BLLRDR and Flint & Embers prepare to launch across Alberta

BLLRDR and Flint & Embers prepare to launch across Alberta

The Flowr Corporation Wins Brand of the Year at ADCANN & Continues to Win Additional Awards

Thu, 28 Jan 2021 00:00 GMT

TORONTO, Jan. 27, 2021 (GLOBE NEWSWIRE) -- The Flowr Corporation (TSX.V: FLWR; OTC: FLWPF) (“Flowr” or the “Company”) has begun 2021 with three wins at the ADCANN Awards - including the coveted Brand of The Year award. The annual awards, which are voted on by the public, exist to celebrate the best marketing and advertising across Canada’s growing cannabis industry. Alongside the Brand of The Year Award, Flowr also won Campaign of the Year for their Rembrandt inspired BC Pink Kush Campaign which works with regulations of the cannabis industry to highlight Flowr’s approach by blending art and science.

MATEON LAUNCHING MOBILE APP, ARTIHEALTH?, FOR REMOTE RESPIRATORY HEALTH ASSESSMENT

Mon, 25 Jan 2021 12:00 GMT

AGOURA HILLS, California, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and infectious diseases, announced that it will be launching its mobile app, ARTIHealth^TM, for respiratory health assessment, in India along with its COVID-19 therapeutic, PulmoHeal^TM also known as ARTIVeda^TM, for total care of COVID-19 patients.

TILT Holdings Inc. Statement on CDA Lawsuit

Sun, 24 Jan 2021 23:19 GMT

PHOENIX, Jan. 24, 2021 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (CSE: TILT) (OTCQX: TLLTF) President Gary Santo provided the following statement regarding the recent actions taken by the Commonwealth Dispensary Association (“CDA”) in Massachusetts.

The Flowr Corporation Announces Private Placement

Sat, 23 Jan 2021 00:27 GMT

TORONTO, Jan. 22, 2021 (GLOBE NEWSWIRE) -- The Flowr Corporation (TSX.V: FLWR; OTC: FLWPF) (“Flowr” or the “Company”) announces that it intends to complete a non-brokered private placement of common shares of Flowr (“Common Shares”) for gross proceeds of up to $1,000,000 (the “Offering”) led by certain directors, officers and insiders. Pursuant to the Offering, the Common Shares will be issued at a price of $0.30 per Common Share. The Company expects to use the proceeds of the Offering for general working capital purposes.

MJardin Announces change in Board of Directors

Mon, 18 Jan 2021 22:00 GMT

NOT FOR RELEASE OR DISSEMINATION INTO THE UNITED STATES

MATEON ANNOUNCES POSITIVE INTERIM RESULTS FROM ARTI-19 CLINICAL TRIAL EVALUATING COVID-19 THERAPEUTIC

Wed, 13 Jan 2021 12:00 GMT

AGOURA HILLS, California, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB: MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and COVID-19, reported positive interim results from its ARTI-19 clinical trial evaluating ARTIVeda^TM against COVID-19.

TILT Holdings Subsidiary Jupiter Research Receives ISO 13485:2016 Medical Device Certification

Tue, 12 Jan 2021 12:00 GMT

Jupiter Research Now Authorized to Design, Manufacture and Distribute Medical Devices within the U.S. and Abroad

Jupiter Research Now Authorized to Design, Manufacture and Distribute Medical Devices within the U.S. and Abroad

TILT Holdings Upgraded to OTCQX? Best Market

Fri, 08 Jan 2021 11:30 GMT

PHOENIX, Jan. 08, 2021 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (TILT or the Company) (CSE: TILT) (OTCQX: TLLTF), a global cannabis company with a portfolio that includes best-in-class inhalation technologies, business solutions, cultivation, manufacturing, processing, distribution, brands and retail, announced that it has been approved for immediate trading on the OTCQX Best Market (“OTCQX”), the top tier of the OTC Markets. Shares of the Company were previously traded on the OTCQB^? Venture Market (“OTCQB”) and will continue to trade under the symbol “TLLTF.”

PainReform to Present at the H.C. Wainwright BioConnect 2021 Conference

Thu, 07 Jan 2021 13:30 GMT

HERZLIYA, Israel, Jan. 07, 2021 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company”), a clinical stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that it will be presenting at the H.C. Wainwright BioConnect 2021 Conference, being held virtually between January 11-14, 2021.

PainReform Appoints Rita Keynan as Vice President of Pharmaceutical Operations

Wed, 06 Jan 2021 13:30 GMT

HERZLIYA, Israel, Jan. 06, 2021 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company”), a clinical stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced the appointment of Rita Keynan as Vice President of Pharmaceutical Operations.

MJardin enters into Supply Agreement for Cannabis Product with the BC Liquor Distribution Branch (BCLDB)

Wed, 06 Jan 2021 13:00 GMT

The Flint & Embers family of products will be available across British Columbia

The Flint & Embers family of products will be available across British Columbia